Addendum to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study

Daniel R. Morales (Lead / Corresponding author), Rob Flynn, Xavier Kurz

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)591-594
Number of pages4
JournalClinical Drug Investigation
Volume39
Issue number6
Early online date14 May 2019
DOIs
Publication statusPublished - Jun 2019

Cite this

@article{66c79b5520fd43968bdcf103285bfb64,
title = "Addendum to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study",
author = "Morales, {Daniel R.} and Rob Flynn and Xavier Kurz",
year = "2019",
month = "6",
doi = "10.1007/s40261-019-00792-7",
language = "English",
volume = "39",
pages = "591--594",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "6",

}

TY - JOUR

T1 - Addendum to

T2 - Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study

AU - Morales, Daniel R.

AU - Flynn, Rob

AU - Kurz, Xavier

PY - 2019/6

Y1 - 2019/6

UR - http://www.scopus.com/inward/record.url?scp=85065971173&partnerID=8YFLogxK

U2 - 10.1007/s40261-019-00792-7

DO - 10.1007/s40261-019-00792-7

M3 - Letter

C2 - 31089972

VL - 39

SP - 591

EP - 594

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 6

ER -